Metabolic Health

HbA1c, insulin sensitivity, lipid panels, and blood pressure beyond weight loss

Beyond the Scale

Weight loss is the headline, but retatrutide's metabolic effects go far deeper. The Phase 2 trial in people with Type 2 diabetes showed HbA1c reductions rivaling dedicated diabetes drugs, alongside improvements in triglycerides, blood pressure, and insulin sensitivity. This unit examines the cardiometabolic data that could make retatrutide relevant well beyond obesity treatment.

Explore the Metabolic Dashboard

Track how retatrutide shifts HbA1c, lipids, blood pressure, and insulin sensitivity across dose tiers and treatment duration.

interactive metabolic dashboard

Knowledge Check

Test what you've learned about retatrutide's metabolic health effects.

Practice Exercises

Reinforce your understanding.